From Wikipedia, the free encyclopedia

Cardiomyopathy
Opened left ventricle showing thickening, dilatation, and subendocardial fibrosis noticeable as increased whiteness of the inside of the heart.
Specialty Cardiology
Symptoms
Complications
Types
Causes
TreatmentDepends on type and symptoms [5]
Frequency2.5 million with myocarditis (2015) [6]
Deaths354,000 with myocarditis (2015) [7]

Cardiomyopathy is a group of primary diseases of the heart muscle. [1] Early on there may be few or no symptoms. [1] As the disease worsens, shortness of breath, feeling tired, and swelling of the legs may occur, due to the onset of heart failure. [1] An irregular heart beat and fainting may occur. [1] Those affected are at an increased risk of sudden cardiac death. [2]

As of 2013, cardiomyopathies are defined as "disorders characterized by morphologically and functionally abnormal myocardium in the absence of any other disease that is sufficient, by itself, to cause the observed phenotype." [8] [9] Types of cardiomyopathy include hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia, and Takotsubo cardiomyopathy (broken heart syndrome). [3] In hypertrophic cardiomyopathy the heart muscle enlarges and thickens. [3] In dilated cardiomyopathy the ventricles enlarge and weaken. [3] In restrictive cardiomyopathy the ventricle stiffens. [3]

In many cases, the cause cannot be determined. [4] Hypertrophic cardiomyopathy is usually inherited, whereas dilated cardiomyopathy is inherited in about one third of cases. [4] Dilated cardiomyopathy may also result from alcohol, heavy metals, coronary artery disease, cocaine use, and viral infections. [4] Restrictive cardiomyopathy may be caused by amyloidosis, hemochromatosis, and some cancer treatments. [4] Broken heart syndrome is caused by extreme emotional or physical stress. [3]

Treatment depends on the type of cardiomyopathy and the severity of symptoms. [5] Treatments may include lifestyle changes, medications, or surgery. [5] Surgery may include a ventricular assist device or heart transplant. [5] In 2015 cardiomyopathy and myocarditis affected 2.5 million people. [6] Hypertrophic cardiomyopathy affects about 1 in 500 people while dilated cardiomyopathy affects 1 in 2,500. [3] [10] They resulted in 354,000 deaths up from 294,000 in 1990. [7] [11] Arrhythmogenic right ventricular dysplasia is more common in young people. [2]

Signs and symptoms

The arrhythmia, ventricular fibrillation, seen on an ECG

Signs and symptoms of cardiomyopathy include:

  • Shortness of breath or trouble breathing, especially with physical exertion
  • Fatigue
  • Swelling in the ankles, feet, legs, abdomen and veins in the neck
  • Dizziness
  • Lightheadedness
  • Fainting during physical activity
  • Arrhythmias (abnormal heartbeats)
  • Chest pain, especially after physical exertion or heavy meals
  • Heart murmurs (unusual sounds associated with heartbeats)

Causes

Cardiomyopathies can be of genetic (familial) or non-genetic (acquired) origin. [12] Genetic cardiomyopathies usually are caused by sarcomere or cytoskeletal diseases, neuromuscular disorders, inborn errors of metabolism, malformation syndromes and sometimes are unidentified. [13] [14] Non-genetic cardiomyopathies can have definitive causes such as viral infections, myocarditis and others. [15] [16]

Cardiomyopathies are either confined to the heart or are part of a generalized systemic disorder, both often leading to cardiovascular death or progressive heart failure-related disability. Other diseases that cause heart muscle dysfunction are excluded, such as coronary artery disease, hypertension, or abnormalities of the heart valves. [17] Often, the underlying cause remains unknown, but in many cases the cause may be identifiable. [18] Alcoholism, for example, has been identified as a cause of dilated cardiomyopathy, as has drug toxicity, and certain infections (including Hepatitis C). [19] [20] [21] Untreated celiac disease can cause cardiomyopathies, which can completely reverse with a timely diagnosis. [22] In addition to acquired causes, molecular biology and genetics have given rise to the recognition of various genetic causes. [20] [23]

A more clinical categorization of cardiomyopathy as 'hypertrophied', 'dilated', or 'restrictive', [24] has become difficult to maintain because some of the conditions could fulfill more than one of those three categories at any particular stage of their development. [25]

The current American Heart Association (AHA) definition divides cardiomyopathies into primary, which affect the heart alone, and secondary, which are the result of illness affecting other parts of the body. These categories are further broken down into subgroups which incorporate new genetic and molecular biology knowledge. [26]

Mechanism

The pathophysiology of cardiomyopathies is better understood at the cellular level with advances in molecular techniques. Mutant proteins can disturb cardiac function in the contractile apparatus (or mechanosensitive complexes). Cardiomyocyte alterations and their persistent responses at the cellular level cause changes that are correlated with sudden cardiac death and other cardiac problems. [27]

Cardiomyopathies are generally varied individually. Different factors can cause Cardiomyopathies in adults as well as children. To exemplify, Dilated Cardiomyopathy in adults is associated with Ischemic Cardiomyopathy, Hypertension, Valvular diseases, and Genetics. While in Children, Neuromuscular diseases such as Becker muscular dystrophy, including X-linked genetic disorder, are directly linked with their Cardiomyopathies. [28]

Diagnosis

Normal sinus rhythm on EKG

Among the diagnostic procedures done to determine a cardiomyopathy are: [29]

Classification

Structural categories of cardiomyopathy
Stained microscopic section of heart muscle in hypertrophic cardiomyopathy

Cardiomyopathies can be classified using different criteria: [30]

Treatment

Treatment may include suggestion of lifestyle changes to better manage the condition. Treatment depends on the type of cardiomyopathy and condition of disease, but may include medication (conservative treatment) or iatrogenic/implanted pacemakers for slow heart rates, defibrillators for those prone to fatal heart rhythms, ventricular assist devices (VADs) for severe heart failure, or catheter ablation for recurring dysrhythmias that cannot be eliminated by medication or mechanical cardioversion. The goal of treatment is often symptom relief, and some patients may eventually require a heart transplant. [29]

See also

References

  1. ^ a b c d e f "What Are the Signs and Symptoms of Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
  2. ^ a b c "Who Is at Risk for Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 16 August 2016. Retrieved 31 August 2016.
  3. ^ a b c d e f g h "Types of Cardiomyopathy". NHLBI. 22 June 2016. Archived from the original on 28 July 2016. Retrieved 31 August 2016.
  4. ^ a b c d e "What Causes Cardiomyopathy?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
  5. ^ a b c d "How Is Cardiomyopathy Treated?". NHLBI. 22 June 2016. Archived from the original on 15 September 2016. Retrieved 31 August 2016.
  6. ^ a b GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi: 10.1016/S0140-6736(16)31678-6. PMC  5055577. PMID  27733282.
  7. ^ a b GBD 2015 Mortality and Causes of Death Collaborators (8 October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi: 10.1016/s0140-6736(16)31012-1. PMC  5388903. PMID  27733281.
  8. ^ Harrison's principles of internal medicine (21st ed.). New York: McGraw Hill. 2022. p. 1954. ISBN  978-1-264-26850-4.
  9. ^ Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L (3 December 2013). "The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy". Journal of the American College of Cardiology. 62 (22): 2046–2072. doi: 10.1016/j.jacc.2013.08.1644. PMID  24263073. S2CID  43240625.
  10. ^ Practical Cardiovascular Pathology. Lippincott Williams & Wilkins. 2010. p. 148. ISBN  978-1-60547-841-8. Archived from the original on 14 September 2016.
  11. ^ GBD 2013 Mortality and Causes of Death Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi: 10.1016/S0140-6736(14)61682-2. PMC  4340604. PMID  25530442.
  12. ^ Bakalakos A, Ritsatos K, Anastasakis A (1 September 2018). "Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view". Hellenic Journal of Cardiology. 59 (5): 254–261. doi: 10.1016/j.hjc.2018.05.008. ISSN  1109-9666. PMID  29807197. S2CID  44146977.
  13. ^ Rath A, Weintraub R (23 July 2021). "Overview of Cardiomyopathies in Childhood". Frontiers in Pediatrics. 9: 708732. doi: 10.3389/fped.2021.708732. ISSN  2296-2360. PMC  8342800. PMID  34368032.
  14. ^ Gorla S, Raja K, Garg A, Barbouth D, Rusconi P (December 2018). "Infantile Onset Hypertrophic Cardiomyopathy Secondary to PRKAG2 Gene Mutation is Associated with Poor Prognosis". Journal of Pediatric Genetics. 07 (4): 180–184. doi: 10.1055/s-0038-1657763. ISSN  2146-4596. PMC  6234042. PMID  30430036.
  15. ^ Law ML, Cohen H, Martin AA, Angulski AB, Metzger JM (February 2020). "Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies". Journal of Clinical Medicine. 9 (2): 520. doi: 10.3390/jcm9020520. ISSN  2077-0383. PMC  7074327. PMID  32075145.
  16. ^ Cimiotti D, Budde H, Hassoun R, Jaquet K (8 January 2021). "Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach". International Journal of Molecular Sciences. 22 (2): 558. doi: 10.3390/ijms22020558. ISSN  1422-0067. PMC  7827163. PMID  33429969.
  17. ^ Lakdawala NK, Stevenson LW, Loscalzo J (2015). "Chapter 287". In Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds.). Harrison's Principles of Internal Medicine (19th ed.). McGraw-Hill. p. 1553. ISBN  978-0-07-180215-4.
  18. ^ Lilly, Leonard S., ed. (2011). Pathophysiology of heart disease: a collaborative project of medical students and faculty (5th ed.). Baltimore, MD: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN  978-1-60547-723-7. OCLC  649701807.
  19. ^ Adam A, Nicholson C, Owens L (2008). "Alcoholic dilated cardiomyopathy". Nurs Stand (Review). 22 (38): 42–7. doi: 10.7748/ns2008.05.22.38.42.c6565. PMID  18578120.
  20. ^ a b Westphal JG, Rigopoulos AG, Bakogiannis C, Ludwig SE, Mavrogeni S, Bigalke B, et al. (2017). "The MOGE(S) classification for cardiomyopathies: current status and future outlook". Heart Fail Rev (Review). 22 (6): 743–752. doi: 10.1007/s10741-017-9641-4. PMID  28721466. S2CID  36117047.
  21. ^ Domont F, Cacoub P (2016). "Chronic hepatitis C virus infection, a new cardiovascular risk factor?". Liver Int (Review). 36 (5): 621–7. doi: 10.1111/liv.13064. PMID  26763484.
  22. ^ Ciaccio EJ, Lewis SK, Biviano AB, Iyer V, Garan H, Green PH (2017). "Cardiovascular involvement in celiac disease". World J Cardiol (Review). 9 (8): 652–666. doi: 10.4330/wjc.v9.i8.652. PMC  5583538. PMID  28932354.
  23. ^ Simpson S, Rutland P, Rutland CS (2017). "Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review". Vet Sci (Review). 4 (1): 19. doi: 10.3390/vetsci4010019. PMC  5606618. PMID  29056678.
  24. ^ Valentin Fuster, John Willis Hurst (2004). Hurst's the heart. McGraw-Hill Professional. p. 1884. ISBN  978-0-07-143225-2. Archived from the original on 27 May 2013. Retrieved 11 November 2010.
  25. ^ Llamas-Esperón GA, Llamas-Delgado G (2022). "Hypertrophic cardiomyopathy. Proposal for a new classification". Arch Cardiol Mex. 92 (3): 377–389. doi: 10.24875/ACM.21000301. PMC  9262289. PMID  35772124.
  26. ^ McCartan C, Maso R, Jayasinghe SR, Griffiths LR (2012). "Cardiomyopathy Classification: Ongoing Debate in the Genomics Era". Biochem Res Int. 2012: 796926. doi: 10.1155/2012/796926. PMC  3423823. PMID  22924131.
  27. ^ Harvey PA, Leinwand LA (8 August 2011). "Cellular mechanisms of cardiomyopathy". The Journal of Cell Biology. 194 (3): 355–365. doi: 10.1083/jcb.201101100. ISSN  0021-9525. PMC  3153638. PMID  21825071.
  28. ^ Braunwald E (15 September 2017). "Cardiomyopathies: An Overview". Circulation Research. 121 (7): 711–721. doi: 10.1161/CIRCRESAHA.117.311812. ISSN  1524-4571. PMID  28912178. S2CID  36384619.
  29. ^ a b "What Are the Signs and Symptoms of Cardiomyopathy? - NHLBI, NIH". nhlbi.nih.gov. Archived from the original on 28 July 2016. Retrieved 25 July 2016.
  30. ^ Vinay K (2013). Robbins Basic Pathology. Elsevier. p. 396. ISBN  978-1-4377-1781-5.
  31. ^ a b c Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (11 April 2006). "Contemporary Definitions and Classification of the Cardiomyopathies". Circulation. 113 (14): 1807–1816. doi: 10.1161/CIRCULATIONAHA.106.174287. ISSN  0009-7322. PMID  16567565. S2CID  6660623. Archived from the original on 20 August 2016. Retrieved 1 August 2016.
  32. ^ a b Séguéla PE, Iriart X, Acar P, Montaudon M, Roudaut R, Thambo JB (2015). "Eosinophilic cardiac disease: Molecular, clinical and imaging aspects". Archives of Cardiovascular Diseases. 108 (4): 258–68. doi: 10.1016/j.acvd.2015.01.006. PMID  25858537.
  33. ^ Rose NR (2016). "Viral myocarditis". Current Opinion in Rheumatology. 28 (4): 383–9. doi: 10.1097/BOR.0000000000000303. PMC  4948180. PMID  27166925.
  34. ^ Lipshultz SE, Messiah SE, Miller TL (5 April 2012). Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues. Springer Science & Business Media. p. 200. ISBN  978-1-4471-2365-1. Archived from the original on 29 May 2016.

Further reading

External links

Look up cardiomyopathy in Wiktionary, the free dictionary.
Scholia has a topic profile for Cardiomyopathy.
Retrieved from " https://en.wikipedia.org/?title=Cardiomyopathy&oldid=1213503679"